₹1,990.5
▼ -0.5%
31 Jul
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. [1] It is the largest pharmaceutical company in India. [2]
● hover near green dot for dividend
| Period | Revenue (cr) | Expenses (cr) | Op. Profit (cr) | Other Inc. (cr) | Interest (cr) | Dep. (cr) | PBT (cr) | Net Profit (cr) | EPS |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2026 | 15,300 | 10,159 | 4,418 | 520 | 99.67 | 739 | 4,099 | 2,901 | ₹12.10 |
| Mar 2026 | 14,612 | 10,199 | 3,954 | 459 | 85.89 | 775 | 3,551 | 2,710 | ₹11.30 |
| Dec 2025 | 15,521 | 9,993 | 4,948 | 89.36 | 78.36 | 732 | 4,227 | 3,381 | ₹14.00 |
| Sep 2025 | 14,478 | 9,481 | 4,527 | 470 | 99.86 | 730 | 4,168 | 3,125 | ₹13.00 |
| Jun 2025 | 13,851 | 9,085 | 4,302 | -354 | 74.80 | 701 | 3,173 | 2,293 | ₹9.50 |
| Mar 2025 | 12,959 | 8,630 | 3,716 | 251 | 49.14 | 664 | 3,254 | 2,154 | ₹9.00 |
| Dec 2024 | 13,675 | 9,516 | 4,010 | 149 | 52.00 | 631 | 3,476 | 2,913 | ₹12.10 |
| Sep 2024 | 13,291 | 8,998 | 3,939 | 354 | 69.00 | 626 | 3,598 | 3,037 | ₹12.67 |
| Jun 2024 | 12,653 | 8,512 | 3,608 | 533 | 62.00 | 655 | 3,424 | 2,861 | ₹11.82 |
| Mar 2024 | 11,983 | 8,443 | 3,036 | 504 | 74.00 | 650 | 2,816 | 2,659 | ₹11.06 |
| Dec 2023 | 12,381 | 8,724 | 3,477 | 180 | 35.00 | 622 | 3,000 | 2,561 | ₹10.52 |
| Sep 2023 | 12,192 | 8,719 | 3,179 | 294 | 49.00 | 633 | 2,791 | 2,385 | ₹9.90 |
| Jun 2023 | 11,941 | 8,728 | 3,331 | -118 | 81.00 | 651 | 2,481 | 2,006 | ₹8.43 |
| Mar 2023 | 10,931 | 7,926 | 2,803 | 202 | 93.00 | 672 | 2,240 | 1,983 | ₹8.27 |
| Dec 2022 | 12,381 | — | 3,477 | — | — | — | — | 2,561 | ₹10.52 |
| Sep 2022 | 12,192 | — | 3,179 | — | — | — | — | 2,385 | ₹9.90 |
| Jun 2022 | 11,941 | — | 3,332 | — | — | — | — | 2,006 | ₹8.43 |
| Period | Total Assets (cr) | Total Equity (cr) | Total Debt (cr) | D/E |
|---|---|---|---|---|
| Mar 2026 | 1,08,785 | 83,570 | 4,082 | 0.05 |
| Mar 2025 | 92,101 | 72,218 | 1,870 | 0.03 |
| Mar 2024 | 85,328 | 63,667 | — | — |
| Mar 2023 | 80,712 | 55,995 | — | — |
| Period | Operating (cr) | Investing (cr) | Financing (cr) | Net Cash (cr) | Free Cash Flow (cr) |
|---|---|---|---|---|---|
| Mar 2026 | 12,419 | -11,344 | -2,513 | -1,437 | 8,906 |
| Mar 2025 | 14,072 | -5,306 | -7,906 | 860 | 12,005 |
